Verve Therapeutics Ratios and Metrics

Market cap in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Aug '25 Aug 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	154,115	96,330	37,012	18,275	20,668	24,811	Upgrade
Market Cap Growth	160.27%	160.27%	102.53%	-11.57%	-16.70%	-28.94%	Upgrade
Enterprise Value	587,417	554,428	495,110	450,369	367,726	371,869	Upgrade
Last Close Price	20.58	18.18	7.05	3.47	3.93	4.73	Upgrade
PS Ratio	0.64	0.40	0.14	0.10	0.24	0.25	Upgrade
PB Ratio	-0.27	-0.17	-0.07	-0.04	-0.05	-0.07	Upgrade
P/FCF Ratio	6.54	4.09	2.04	-	-	-	Upgrade
P/OCF Ratio	6.10	3.81	1.65	-	-	-	Upgrade
EV/Sales Ratio	2.45	2.31	1.91	2.52	4.17	3.75	Upgrade
EV/EBITDA Ratio	18.26	22.04	37.62	-	-	-	Upgrade
EV/EBIT Ratio	38.02	35.88	165.49	-	-	-	Upgrade
EV/FCF Ratio	24.94	23.54	27.27	-	-	-	Upgrade
Debt / Equity Ratio	-0.79	-0.79	-0.83	-0.90	-0.97	-0.94	Upgrade
Debt / EBITDA Ratio	13.79	13.79	22.71	-	-	104.96	Upgrade
Debt / FCF Ratio	18.84	18.84	25.34	-	-	-	Upgrade
Asset Turnover	0.60	0.60	0.72	0.59	0.32	0.35	Upgrade
Inventory Turnover	44.53	44.53	57.87	54.84	32.68	29.78	Upgrade
Quick Ratio	0.09	0.09	0.06	0.11	0.12	0.11	Upgrade
Current Ratio	0.14	0.14	0.11	0.14	0.15	0.14	Upgrade
Return on Assets (ROA)	2.42%	2.42%	0.52%	-3.68%	-5.05%	-3.04%	Upgrade
Earnings Yield	-10.09%	-16.14%	-236.13%	-532.42%	-258.25%	-175.54%	Upgrade
FCF Yield	15.28%	24.45%	49.06%	-25.20%	-123.66%	-59.32%	Upgrade

Updated Oct 30, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.